Nurexone Biologic Inc
F:J90

Watchlist Manager
Nurexone Biologic Inc Logo
Nurexone Biologic Inc
F:J90
Watchlist
Price: 0.441 EUR 12.5% Market Closed
Market Cap: €29.6m

Nurexone Biologic Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nurexone Biologic Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Nurexone Biologic Inc
F:J90
Other Items
-$9k
CAGR 3-Years
83%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Precision Drilling Corp
TSX:PD
Other Items
CA$24.6m
CAGR 3-Years
-13%
CAGR 5-Years
10%
CAGR 10-Years
-6%
Enerflex Ltd
TSX:EFX
Other Items
CA$28m
CAGR 3-Years
16%
CAGR 5-Years
-1%
CAGR 10-Years
6%
T
TerraVest Industries Inc
TSX:TVK
Other Items
-CA$880.2m
CAGR 3-Years
-201%
CAGR 5-Years
-202%
CAGR 10-Years
-49%
CES Energy Solutions Corp
TSX:CEU
Other Items
-CA$2.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
16%
Secure Energy Services Inc
TSX:SES
Other Items
-CA$115m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-5%
No Stocks Found

Nurexone Biologic Inc
Glance View

Market Cap
29.6m EUR
Industry
N/A

NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles (EV)-based technology drug platform. The company is headquartered in Edmonton, Alberta. The company went IPO on 2012-05-08. The firm is developing a biological extracellular vesicles (EV)-based technology drug platform. The technology drug platform offers treatment for reversing paralysis and improving the life of patients following spinal cord injury using bio-guided exosomes (membrane-bound extracellular vesicles) loaded with modified small interfering RNA (siRNA) sequence. Its technology is used to treat various conditions, such as spinal cord injury, traumatic brain injury, and other brain and neurological indications. The firm also has developed exosome manufacturing process. The company is also focused on exosome research, management of clinical studies and commercialization of the technology for different indications, not limited to the central nervous system.

J90 Intrinsic Value
0.031 EUR
Overvaluation 93%
Intrinsic Value
Price

See Also

What is Nurexone Biologic Inc's Other Items?
Other Items
-9k USD

Based on the financial report for Dec 31, 2024, Nurexone Biologic Inc's Other Items amounts to -9k USD.

What is Nurexone Biologic Inc's Other Items growth rate?
Other Items CAGR 3Y
83%

The average annual Other Items growth rates for Nurexone Biologic Inc have been 83% over the past three years .

Back to Top